Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -110.62% is 78% below its 5-year average of -62.22%, near the low end of its 5-year range (-119.50%–-17.21%).
As of the fiscal period ended Tuesday, June 30, 2026. 3.84% below its 12-month average of -106.54%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -110.62%.
RETURN ON INVESTED CAPITAL (ROIC)
-110.62%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-106.54%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-80.84%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-62.22%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-3.84%
CURRENT VS 3Y AVG
-36.84%
CURRENT VS 5Y AVG
-77.80%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
-210.35%
vs the sector median at left
Faeth Therapeutics, Inc.
Market Cap
$716.26M
Return on Invested Capital (ROIC)
-110.62%
TTM Avg
-106.54%
3Y Avg
-80.84%
5Y Avg
-62.22%
Market Cap
$719.10M
Return on Invested Capital (ROIC)
-19.45%
TTM Avg
-59.05%
3Y Avg
-125.75%
5Y Avg
-106.53%
Market Cap
$714.16M
Return on Invested Capital (ROIC)
-12.00%
TTM Avg
-7.53%
3Y Avg
-5.45%
5Y Avg
-2.27%
Market Cap
$714.19M
Return on Invested Capital (ROIC)
6.11%
TTM Avg
9.98%
3Y Avg
8.97%
5Y Avg
8.63%
Market Cap
$732.47M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-136.50%
3Y Avg
-154.74%
5Y Avg
-122.58%
Market Cap
$735.63M
Return on Invested Capital (ROIC)
-36.83%
TTM Avg
-41.75%
3Y Avg
-59.42%
5Y Avg
-51.49%
Market Cap
$694.48M
Return on Invested Capital (ROIC)
-41.63%
TTM Avg
-2189.24%
3Y Avg
-1224.39%
5Y Avg
-874.41%
Market Cap
$694.41M
Return on Invested Capital (ROIC)
-50.92%
TTM Avg
-35.84%
3Y Avg
-41.63%
5Y Avg
-32.97%
Market Cap
$692.54M
Return on Invested Capital (ROIC)
-42.94%
TTM Avg
-42.70%
3Y Avg
-94.89%
5Y Avg
-93.87%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Faeth Therapeutics, Inc. (FTH) | $716.26M | -110.62% | -106.54% | -80.84% | -62.22% |
| Avalo Therapeutics, Inc. (AVTX)vs › | $719.10M | -19.45% | -59.05% | -125.75% | -106.53% |
| Cytek Biosciences, Inc. (CTKB)vs › | $714.16M | -12.00% | -7.53% | -5.45% | -2.27% |
| Collegium Pharmaceutical, Inc. (COLL)vs › | $714.19M | 6.11% | 9.98% | 8.97% | 8.63% |
| Achieve Life Sciences, Inc. (ACHV)vs › | $732.47M | N/A | -136.50% | -154.74% | -122.58% |
| Candel Therapeutics, Inc. (CADL)vs › | $735.63M | -36.83% | -41.75% | -59.42% | -51.49% |
| Anteris Technologies Global Corp. (AVR)vs › | $694.48M | -41.63% | -2189.24% | -1224.39% | -874.41% |
| Olema Pharmaceuticals, Inc. (OLMA)vs › | $694.41M | -50.92% | -35.84% | -41.63% | -32.97% |
| Wave Life Sciences Ltd. (WVE)vs › | $692.54M | -42.94% | -42.70% | -94.89% | -93.87% |
| Verastem, Inc. (VSTM)vs › | $687.61M | -118.97% | -130.14% | -108.49% | -89.69% |
ROIC
-110.6%
ROE
-113.0%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -110.62% |
| 2026-03-31 | -97.10% |
| 2025-12-31 | -119.50% |
| 2025-09-30 | -106.48% |
| 2025-06-30 | -98.98% |
| 2025-03-31 | -91.41% |
| 2024-12-31 | -79.33% |
| 2024-09-30 | -67.94% |
| 2024-06-30 | -59.06% |
| 2024-03-31 | -56.39% |
| 2023-12-31 | -53.94% |
| 2023-09-30 | -54.23% |
| 2023-06-30 | -55.94% |
| 2023-03-31 | -46.42% |
| 2022-12-31 | -44.94% |
| 2022-09-30 | -38.69% |
| 2022-06-30 | -32.37% |
| 2022-03-31 | -29.49% |
| 2021-12-31 | -25.27% |
| 2021-09-30 | -21.25% |
| 2021-06-30 | -17.21% |
| 2021-03-31 | -13.56% |
| 2020-12-31 | -117.19% |
| 2020-09-30 | -540.62% |
